4.6 Article Proceedings Paper

Aurora-A kinase nuclear expression in chronic lymphocytic leukemia

Journal

MODERN PATHOLOGY
Volume 21, Issue 12, Pages 1428-1435

Publisher

NATURE PUBLISHING GROUP
DOI: 10.1038/modpathol.2008.173

Keywords

Aurora-A; CLL; chromatin; chromosomes; p53

Categories

Ask authors/readers for more resources

Aurora-A kinase is a cell-cycle-regulating kinase required for chromosomal segregation. Overexpression of Aurora-A kinase has been shown to correlate with tumor proliferation and chromosomal instability. We investigated Aurora-A kinase expression in peripheral blood and bone marrow of 47 chronic lymphocytic leukemia patients and 20 age-matched hematologically healthy subjects. Western blot analysis showed significantly higher Aurora-A levels in chronic lymphocytic leukemia (42 of 47) compared with lymphocytes of healthy subjects. However, Aurora-A mRNA expression in three chronic lymphocytic leukemia patients was similar to or lower than that of healthy control subjects. In 28 of 42 chronic lymphocytic leukemia patients with elevated Aurora-A kinase expression, one or more chromosomal abnormalities were detected, including trisomy 12 in 9 patients and deletion of the ataxia telangiectasia-mutated gene in 9 patients. Aurora-A was also detected in all (100%) chronic lymphocytic leukemia cases by immunohistochemistry, with a nuclear staining pattern. The larger prolymphocytes and paraimmunoblasts showed stronger Aurora-A kinase expression than did small lymphocytes. In contrast, normal bone marrow reactive lymphocytes were negative for Aurora-A with positive histiocytes and immature myeloid cells. Immunostaining for acetylated histone H3 showed a nuclear pattern in all 38 chronic lymphocytic leukemia cases and double labeling showed coexpression of acetylated histone H3 and Aurora-A. In summary, Aurora-A kinase is overexpressed in chronic lymphocytic leukemia cells. The expression of acetylated histone H3 suggests that Aurora-A kinase may be active (functional). Thus, Aurora-A kinase overexpression in chronic lymphocytic leukemia may be involved in the genesis of chromosomal abnormalities and is a potential target for therapeutic intervention.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.6
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

Article Cell Biology

Kikuchi disease with an exuberant proliferation of large T-cells: a study of 25 cases that can mimic T-Cell lymphoma

Fang Yu, Xiaoqun Ba, Hanjin Yang, Ke Huang, Yafei Zhang, Han Zhang, Liming Xu, Jinghan Wang, Lijun Wang, Zhaoming Wang, Hong Fang, L. Jeffrey Medeiros, Wei Wang

Summary: Exuberant large T-cell proliferations in Kikuchi disease can be misdiagnosed as lymphoma, but a comprehensive analysis of clinical, pathological, and immunophenotypic features can help distinguish between the two.

HISTOPATHOLOGY (2023)

Article Pathology

Overexpression of interleukin-20 correlates with favourable prognosis in diffuse large B-cell lymphoma

Yi-Sian Lu, Po-Min Chiang, Yi-Ching Huang, Shiang-Jie Yang, Liang-Yi Hung, L. Jeffrey Medeiros, Ya-Ping Chen, Tsai-Yun Chen, Ming-Shi Chang, Kung-Chao Chang

Summary: Diffuse large B-cell lymphoma (DLBCL) is the most common type of lymphoma worldwide. This study found that interleukin-20 (IL-20) is frequently expressed in different types of lymphoma, especially in follicular lymphoma, Burkitt lymphoma, and mantle cell lymphoma. Overexpression of IL-20 promotes cell apoptosis in DLBCL.

PATHOLOGY (2023)

Letter Pathology

Intracranial inflammation-rich germinoma mimicking haematological neoplasms: a diagnostic pitfall

Tsung-Heng Tsai, Che-Wei Hsu, L. Jeffrey Medeiros, Kung-Chao Chang

PATHOLOGY (2023)

Article Pathology

Classic Hodgkin lymphoma with marked granulomatous reaction: A clinicopathologic study of 20 cases

Jie Xu, Shaoying Li, C. Cameron Yin, Keyur P. Patel, Guilin Tang, Wei Wang, Roberto N. Miranda, Sofia Garces, Zhenya Tang, Pei Lin, L. Jeffrey Medeiros

Summary: Granulomatous reactions can occur in patients with Hodgkin lymphoma and have distinct clinical and pathological features. These patients are predominantly male and usually over 40 years old. They commonly present with lymphadenopathy, particularly in the neck and supraclavicular areas. Advanced stage disease and B symptoms are frequently observed. The histiocytes in the granulomas express PD-L1 and pSTAT3, but not pERK and cyclin D1. The 5-year overall survival rate for these patients is 78%.

HUMAN PATHOLOGY (2023)

Article Pathology

T-Cell Prolymphocytic Leukemia With t(X;14)(q28;q11.2): A Clinicopathologic Study of 15 Cases

Zhihong Hu, L. Jeffrey Medeiros, Mina Xu, Ji Yuan, Deniz Peker, Lina Shao, Zhenya Tang, Brenda Mai, Beenu Thakral, Adan Rios, Shimin Hu, Wei Wang

Summary: This study aimed to investigate the clinicopathologic features and molecular profile of T-PLL associated with t(X;14)(q28;q11.2). The results showed that T-PLL patients with t(X;14)(q28;q11.2) frequently have lymphocytosis, morphological abnormalities in leukemic cells, complex karyotypes, and mutations involving JAK/STAT pathway. The overall survival rate was poor, with 8 out of 15 patients dying during the follow-up period.

AMERICAN JOURNAL OF CLINICAL PATHOLOGY (2023)

Article Pathology

Immunophenotypic and genomic landscape of Richter transformation diffuse large B-cell lymphoma

Siba El Hussein, Kirill A. Lyapichev, Hong Fang, Fatima Zahra Jelloul, Warren Fiskus, Jiansong Chen, Peng Wei, Ellen Schlette, Jie Xu, Shaoying Li, Rashmi Kanagal-Shamanna, Hong Yang, Zhenya Tang, Beenu Thakral, Sanam Loghavi, Nitin Jain, Philip A. Thompson, Alessandra Ferrajoli, William G. Wierda, Elias Jabbour, Keyur P. Patel, Bouthaina S. Dabaja, Kapil N. Bhalla, Joseph D. Khoury

Summary: Integrated clinicopathological and molecular analyses were performed on 142 cases of RT-DLBCL. The study found that RT-DLBCL has distinctive morphological and immunophenotypic features, including immunoblastic morphology and common expression of CD5, MUM1, and LEF1. Cell-of-origin does not seem to have prognostic implications in RT-DLBCL.

PATHOLOGY (2023)

Article Pathology

Immune evasion phenotype is common in Richter transformation diffuse large B-cell lymphoma variant

Siba El Hussein, L. Jeffrey Medeiros, Stephen K. Gruschkus, Peng Wei, Ellen Schlette, Hong Fang, Fatima Zahra Jelloul, Wei Wang, Warren Fiskus, Rashmi Kanagal-Shamanna, Sanam Loghavi, Hong Yang, Shaoying Li, Jie Xu, Zhenya Tang, Beenu Thakral, Nitin Jain, William G. Wierda, Keyur Patel, Kapil N. Bhalla, Joseph D. Khoury

Summary: Immune checkpoint inhibitors (PD-1 inhibitors) have shown clinical activity in Richter transformation-diffuse large B-cell lymphoma variant (RT-DLBCL), providing a novel therapeutic approach. A study group of 64 RT-DLBCL patients was assessed for expression of PD-1, PD-L1, CD30, and microsatellite instability (MSI), as well as evaluated for immune evasion phenotype (IEP) and PD1-positive tumor-infiltrating lymphocytes (TILs). Brisk PD1+ TIL level was more common in IEP+ tumors, and CD30 expression was significantly more common in IEP+ RT-DLBCL. There was no significant difference in age, sex, or time to transformation between the two groups. Notably, patients with brisk PD1+ TILs had better overall survival.

VIRCHOWS ARCHIV (2023)

Article Oncology

Clinical impact of 5'MYC or 3'MYC gain/loss detected by FISH in patients with aggressive B-cell lymphomas

Guilin Tang, Shaoying Li, Gokce A. Toruner, Preetesh Jain, Zhenya Tang, Shimin Hu, Jie Xu, Joanne Cheng, Melissa Robinson, Francisco Vega, L. Jeffrey Medeiros

Summary: FISH analysis using MYC break-apart probes is a commonly used technique to assess for MYC rearrangement. However, atypical signal patterns can occur, such as gain or loss of 5'MYC or 3'MYC. This study evaluated patients with aggressive B-cell lymphomas who exhibited atypical FISH signal patterns and found that 5'MYC gain is associated with MYC expression and a poorer prognosis, while 3'MYC deletions are not associated with MYC expression or a poorer prognosis and may be unrelated to MYC-R.

CANCER GENETICS (2023)

Article Oncology

Detection of clinically actionable gene fusions by next-generation sequencing-based RNA sequencing of non-small cell lung cancer cytology specimens: A single-center experience with comparison to fluorescence in situ hybridization

John Diks, Zhenya Tang, Mehmet Altan, Sarah Anderson, Hui Chen, Asif Rashid, Richard Kenneth Yang, Mark J. Routbort, Keyur P. Patel, Gokce A. Toruner, L. Jeffrey Medeiros, Guilin Tang, Rajyalakshmi Luthra, Sinchita Roy-Chowdhuri

Summary: This study evaluated the efficacy of RNA-based NGS assay in detecting genomic alterations in NSCLC cytology specimens and compared the results with FISH testing. The results showed that RNA-based NGS can accurately detect gene fusions in NSCLC cytology with high concordance with FISH results. However, RNA-based NGS may have high failure rates, suggesting the need for orthogonal testing for comprehensive genomic profiling.

CANCER CYTOPATHOLOGY (2023)

Letter Pathology

TdT-positive high-grade B-cell lymphoma with BCOR and IDH1 mutations

Yu-Ting Yu, Kuan-Yu Lin, Ya-Ping Chen, Yi-Lin Chen, L. Jeffrey Medeiros, Kung-Chao Chang

PATHOLOGY (2023)

Meeting Abstract Medicine, Research & Experimental

Next-Generation Sequencing Identifies Approximately One Third of Mantle Cell Lymphoma Patients with Nuclear Factor-kappa B Pathway Mutations

Do Hwan Kim, Fatima Zahra Jelloul, Sanam Loghavi, Rashmi Kanagal-Shamanna, C. Cameron Yin, Zhuang Zuo, Keyur Patel, Mark Routbort, Shaoying Li, Francisco Vega, Roberto Miranda, L. Jeffrey Medeiros, Chi Young Ok

LABORATORY INVESTIGATION (2023)

Meeting Abstract Medicine, Research & Experimental

MYC and BCL6 Double Hit Lymphoma (DHL): A Clinicopathologic Study of 60 Cases in Comparison to BCL2-DHL and Diffuse Large B-cell Lymphoma (DLBCL)

Do Hwan Kim, Guilin Tang, Pei Lin, Jie Xu, Sa Wang, Lianqun Qiu, C. Cameron Yin, Wei Wang, L. Jeffrey Medeiros, Shaoying Li

LABORATORY INVESTIGATION (2023)

Meeting Abstract Medicine, Research & Experimental

Myeloid Neoplasms with t(2;3)(p21∼23;3q26.2): a Report of 21 Cases

Meng Liu, Xiaoqiong Wang, E. Shuyu, Guilin Tang, Wei Wang, Fatima Zahra Jelloul, Pei Lin, L. Jeffrey Medeiros, Shimin Hu

LABORATORY INVESTIGATION (2023)

Meeting Abstract Medicine, Research & Experimental

Bone Marrow Immunophenotype and Genotype Characteristics Assessed by Flow Cytometry and Next Generation Sequencing in 147 Patients with Myeloid Sarcoma

Karen Nahmod, Beenu Thakral, Wei Wang, Fnu Aakash, Keyur Patel, Mark Routbort, Rashmi Kanagal-Shamanna, Chi Young Ok, Guilin Tang, Francisco Vega, L. Jeffrey Medeiros, Sa Wang, Sanam Loghavi

LABORATORY INVESTIGATION (2023)

Meeting Abstract Medicine, Research & Experimental

Immunophenotype and Cytogenetic Abnormalities in Plasma Cells of Lymphoplasmacytic Lymphoma and their Roles in Differential Diagnosis

Karen Nahmod, Sa Wang, Shaoying Li, Zhenya Tang, Fnu Aakash, Jie Xu, Shimin Hu, L. Jeffrey Medeiros, Guilin Tang

LABORATORY INVESTIGATION (2023)

Article Pathology

Analysis of B7-H4 Expression Across Salivary Gland Carcinomas Reveals Adenoid Cystic Carcinoma-Specific Prognostic Relevance

Juliana Mota Siqueira, Yoshitsugu Mitani, Camilla Oliveira Hoff, Flavia Bonini, Luana Guimaraes de Sousa, Mario L. Marques-Piubelli, Anurag Purushothaman, Mutsumi Mitani, Hui Dai, Shiaw-Yih Lin, Michael T. Spiotto, Ehab Y. Hanna, Daniel J. McGrail, Adel K. El-Naggar, Renata Ferrarotto

Summary: B7-H4 expression pattern varies among different types of salivary gland carcinomas, and high B7-H4 expression is associated with poor prognosis in adenoid cystic carcinoma.

MODERN PATHOLOGY (2024)

Article Pathology

Dedifferentiated and Undifferentiated Ovarian Carcinoma: An Aggressive and Molecularly Distinct Ovarian Tumor Characterized by Frequent SWI/SNF Complex Inactivation

Basile Tessier-Cloutier, Felix K. F. Kommoss, David L. Kolin, Kristyna Nemejcova, Dupreez Smith, Jennifer Pors, Colin J. R. Stewart, W. Glenn Mccluggage, William D. Foulkes, Andreas von Deimling, Martin Kobel, Cheng-Han Lee

Summary: This study provides a detailed analysis of the clinical, pathological, immunohistochemical, and molecular features of DDOC/UDOC. The majority of patients presented with extraovarian disease and had rapid disease progression resulting in high mortality rate.

MODERN PATHOLOGY (2024)

Review Pathology

Built to Last? Reproducibility and Reusability of Deep Learning Algorithms in Computational Pathology

Sophia J. Wagner, Christian Matek, Sayedali Shetab Boushehri, Melanie Boxberg, Lorenz Lamm, Ario Sada, Dominik J. E. Winter, Carsten Marr, Tingying Peng

Summary: Computational pathology research driven by deep learning faces challenges in reproducibility and reusability. Codebase with good documentation and robustness and generalizability of models are crucial. The reuse of computational pathology algorithms is limited, and their application in clinical settings is even rarer. This study evaluates 160 peer-reviewed articles, providing criteria for data and code availability and statistical analysis of results.

MODERN PATHOLOGY (2024)

Article Pathology

Testicular Neoplasms With Sex Cord and Stromal Components Harbor a Recurrent Pattern of Chromosomal Gains

Andres M. Acosta, Lynette M. Sholl, Fiona Maclean, Chia-Sui Kao, Thomas M. Ulbright

Summary: This study assessed the clinicopathologic and genomic features of 14 cases of testicular sex cord-stromal tumors. The results showed that CTNNB1 mutations are rare in these tumors, and most of them have genomic alterations similar to testicular sex cord-stromal tumors with pure or predominant spindle cell components.

MODERN PATHOLOGY (2024)

Article Pathology

Inflammatory Rhabdomyoblastic Tumor: Clinicopathologic and Molecular Analysis of 13 Cases

Toru Odate, Kaishi Satomi, Takashi Kubo, Yuko Matsushita, Toshihide Ueno, Akira Kurose, Kohei Shomori, Tokiko Nakai, Reiko Watanabe, Keiko Segawa, Shusa Ohshika, Naritomo Miyake, Sayaka Kudo, Tatsunori Shimoi, Eisuke Kobayashi, Motokiyo Komiyama, Seiichi Yoshimoto, Fumihiko Nakatani, Akira Kawai, Yasushi Yatabe, Shinji Kohsaka, Koichi Ichimura, Hitoshi Ichikawa, Akihiko Yoshida

Summary: Inflammatory rhabdomyoblastic tumors (IRMTs) are newly recognized skeletal muscle tumors with uncertain malignant potential. This study investigated 13 IRMTs using clinicopathologic, genetic, and epigenetic methods. The results showed specific histologic features and genetic mutations in these tumors, and most of them exhibited benign behavior.

MODERN PATHOLOGY (2024)

Article Pathology

Outcome-Based Risk Stratification Model for the Diagnosis of Placental Maternal Vascular Malperfusion

Dale L. Davis, Adam C. Lechner, David B. Chapel, Jonathan C. Slack, Chrystalle Katte Carreon, Bradley J. Quade, Carlos Parra-Herran

Summary: The Amsterdam Consensus Statement introduced the term maternal vascular malperfusion (MVM) to classify a group of findings related to impaired maternal-placental circulation. The study found that features such as low placental weight, accelerated villous maturation, decidual arteriopathy, and infarcts are associated with adverse obstetrical outcomes, while the role of other features like distal villous hypoplasia, excess multinucleated trophoblast, and retroplacental hemorrhage needs further research.

MODERN PATHOLOGY (2024)

Review Pathology

Pathogenesis of Pulmonary Long COVID-19

Alain C. Borczuk

Summary: COVID-19 is an acute respiratory illness that can progress to acute respiratory distress syndrome. While most patients recover completely, some may experience persistent respiratory dysfunction, known as long COVID. The pathogenesis involves immune and cellular disturbances.

MODERN PATHOLOGY (2024)

Article Pathology

Pathologic Processing of Lung Cancer Resection Specimens After Neoadjuvant Therapy

Annikka Weissferdt, Cheuk H. Leung, Heather Lin, Boris Sepesi, William N. William, Stephen G. Swisher, Tina Cascone, J. Jack Lee, Abujiang Pataer

Summary: Neoadjuvant treatment of non-small cell lung cancer challenges traditional processing of pathology specimens, and accurate evaluation of residual tumor is crucial for assessing treatment efficacy.

MODERN PATHOLOGY (2024)